高瓴资本旗下高济医疗拟通过香港IPO筹资超5亿美元

和讯2023-03-21

快讯摘要高瓴资本旗下高济医疗拟通过香港IPO筹资超5亿美元：彭博援引知情人士报道，高瓴资本旗下的药品零售平台高济医疗拟通过在香港的首次公开募股(IPO)筹资超5亿美元。美国银行、高盛集团和海通国际等...快讯正文高瓴资本旗下高济医疗拟通过香港IPO筹资超5亿美元：彭博援引知情人士报道，高瓴资本旗下的药品零售平台高济医疗拟通过在香港的首次公开募股(IPO)筹资超5亿美元。美国银行、高盛集团和海通国际...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2321695207?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2023-03-21 09:58","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2321695207","market":"us","top_or_hot":-1,"title":"高瓴资本旗下高济医疗拟通过香港IPO筹资超5亿美元","media":"和讯","content":"<div>\n<p>快讯摘要高瓴资本旗下高济医疗拟通过香港IPO筹资超5亿美元：彭博援引知情人士报道，高瓴资本旗下的药品零售平台高济医疗拟通过在香港的首次公开募股(IPO)筹资超5亿美元。美国银行、高盛集团和海通国际等...快讯正文高瓴资本旗下高济医疗拟通过香港IPO筹资超5亿美元：彭博援引知情人士报道，高瓴资本旗下的药品零售平台高济医疗拟通过在香港的首次公开募股(IPO)筹资超5亿美元。美国银行、高盛集团和海通国际...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230321100021841c015d&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>高瓴资本旗下高济医疗拟通过香港IPO筹资超5亿美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n高瓴资本旗下高济医疗拟通过香港IPO筹资超5亿美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-03-21 09:58 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230321100021841c015d&s=b><strong>和讯</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>快讯摘要高瓴资本旗下高济医疗拟通过香港IPO筹资超5亿美元：彭博援引知情人士报道，高瓴资本旗下的药品零售平台高济医疗拟通过在香港的首次公开募股(IPO)筹资超5亿美元。美国银行、高盛集团和海通国际等...快讯正文高瓴资本旗下高济医疗拟通过香港IPO筹资超5亿美元：彭博援引知情人士报道，高瓴资本旗下的药品零售平台高济医疗拟通过在香港的首次公开募股(IPO)筹资超5亿美元。美国银行、高盛集团和海通国际...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230321100021841c015d&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1201861165.SGD","symbol_name":"Natixis Harris Associates Global Equity PA SGD","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230321100021841c015d&s=b","article_id":"2321695207","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230321100021841c015d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2321695207","pubTimestamp":1679363891,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"快讯摘要高瓴资本旗下高济医疗拟通过香港IPO筹资超5亿美元：彭博援引知情人士报道，高瓴资本旗下的药品零售平台高济医疗拟通过在香港的首次公开募股(IPO)筹资超5亿美元。美国银行、高盛集团和海通国际等...快讯正文高瓴资本旗下高济医疗拟通过香港IPO筹资超5亿美元：彭博援引知情人士报道，高瓴资本旗下的药品零售平台高济医疗拟通过在香港的首次公开募股(IPO)筹资超5亿美元。美国银行、高盛集团和海通国际等将负责潜在的股票销售。其中一位人士说，IPO最快可能在今年下半年发生。(界面新闻)下载和讯APP查看快讯，体验更佳>>","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LU1201861165.SGD":"Natixis Harris Associates Global Equity PA SGD","IE00BKVL7J92.USD":"Legg Mason ClearBridge - US Equity Sustainability Leaders A Acc USD","LU2133065610.SGD":"JPMorgan Investment Funds - Global Dividend A (mth) SGD","LU1668664300.SGD":"Blackrock World Financials A2 SGD-H","LU1496350171.SGD":"FRANKLIN DIVERSIFIED BALANCED \"A\" (SGDHDG) ACC","LU1201861249.SGD":"Natixis Harris Associates US Equity PA SGD-H","LU1496350502.SGD":"FRANKLIN DIVERSIFIED DYNAMIC \"A\" (SGDHDG) ACC","IE00BLSP4239.USD":"Legg Mason ClearBridge - Tactical Dividend Income A Mdis USD Plus","IE00BLSP4452.SGD":"Legg Mason ClearBridge - Tactical Dividend Income A Mdis SGD-H Plus","BK4553":"喜马拉雅资本持仓","LU0980610538.SGD":"Natixis Harris Associates US Equity RA SGD-H","BK4585":"ETF&股票定投概念","BK4534":"瑞士信贷持仓","IE00B19Z3581.USD":"Legg Mason ClearBridge - Value A Acc USD","LU0053666078.USD":"摩根大通基金-美国股票A（离岸）美元","LU0208291251.USD":"FRANKLIN MUTUAL U.S. VALUE \"A\" (USD) INC","IE00B19Z3B42.SGD":"Legg Mason ClearBridge - Value A Acc SGD","LU1162221912.USD":"FRANKLIN INCOME \"A\" (USD) ACC","BK4559":"巴菲特持仓","IE00B7SZLL34.SGD":"Legg Mason ClearBridge - Value A Acc SGD-H","IE00BBT3K403.USD":"LEGG MASON CLEARBRIDGE TACTICAL DIVIDEND INCOME \"A(USD) ACC","BK4588":"碎股","LU0130103400.USD":"Natixis Harris Associates Global Equity RA USD","LU0320765646.SGD":"FTIF - Franklin Income A MDIS SGD-H1","BK4207":"综合性银行","IE00BZ1G4Q59.USD":"LEGG MASON CLEARBRIDGE US EQUITY SUSTAINABILITY LEADER \"A\"(USD) INC (A)","LU0106831901.USD":"贝莱德世界金融基金A2","LU1363072403.SGD":"Fidelity Global Financial Services A-ACC-SGD","LU0320765489.SGD":"FTIF - Franklin Mutual US Value A Acc SGD","BAC":"美国银行","LU0648000940.SGD":"Natixis Harris Associates Global Equity RA SGD","LU0130102774.USD":"Natixis Harris Associates US Equity RA USD","LU0070302665.USD":"FRANKLIN MUTUAL U.S. VALUE \"A\" (USD) ACC","BK4504":"桥水持仓","BK4581":"高盛持仓","LU0648001328.SGD":"Natixis Harris Associates US Equity RA SGD","IE0002270589.USD":"LEGG MASON CLEARBRIDGE VALUE \"A\" (USD) INC","LU0868494617.USD":"UBS (LUX) EQUITY SICAV - US TOTAL YIELD SUSTAINABLE \"P\" (USD) ACC","LU0971096721.USD":"富达环球金融服务 A","LU1718418525.SGD":"JPMorgan Investment Funds - Global Select Equity A (acc) SGD","GS":"高盛","LU0149725797.USD":"汇丰美国股市经济规模基金"},"translate_title":"Gaoji Medical, a subsidiary of Gaochun Capital, plans to raise more than 500 million US dollars through Hong Kong IPO","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BAC":0.9,"00665":0.9,"GS":0.9},"content_text":"快讯摘要高瓴资本旗下高济医疗拟通过香港IPO筹资超5亿美元：彭博援引知情人士报道，高瓴资本旗下的药品零售平台高济医疗拟通过在香港的首次公开募股(IPO)筹资超5亿美元。美国银行、高盛集团和海通国际等...快讯正文高瓴资本旗下高济医疗拟通过香港IPO筹资超5亿美元：彭博援引知情人士报道，高瓴资本旗下的药品零售平台高济医疗拟通过在香港的首次公开募股(IPO)筹资超5亿美元。美国银行、高盛集团和海通国际等将负责潜在的股票销售。其中一位人士说，IPO最快可能在今年下半年发生。(界面新闻)下载和讯APP查看快讯，体验更佳>>","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2321695207"}